Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Science 37 has raised $200.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2021.
Science 37's investors include BlackRock, Lux Capital, Perceptive Advisors, Novartis, Redmile Group.
Science 37 is headquartered in Culver City, United States.
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Science 37 is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Science 37 — Funding & Investors." VCBacked, October 7, 2021, https://www.vcbacked.co/company/science-37. Accessed August 14, 2026.
VCBacked. (2021). Science 37 — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/science-37
{{cite web |title=Science 37 — Funding & Investors |url=https://www.vcbacked.co/company/science-37 |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated